Pharmacokinetics of Meptazinol in Man Following Repeated Intramuscular Administration
Overview
Affiliations
A study was performed in 6 healthy volunteers to determine whether 50 mg intramuscular doses of meptazinol repeated four hourly for 24 h would lead to accumulation of the drug. The first dose of meptazinol was rapidly absorbed with a subsequent mean (+/- SD) elimination half-life of 1.6 +/- 0.33 h. This value was unaffected by the administration of intermediate doses. There was no significant accumulation of the drug; 95% of the steady-state plasma concentration was achieved after a mean (+/- SD) of 1.9 +/- 0.39 and 99% after a mean (+/- SD) of 2.9 +/- 0.63 doses. These findings are consistent with the theoretical prediction for a rapidly absorbed drug with a plasma elimination half-life of 1.6 h. No clinically relevant changes were seen in pulse blood pressure, haematological or biochemical screens. Reported side effects were of a subjective and minor nature.
Enhanced oral bioavailability of meptazinol in cirrhosis.
Birnie G, Thompson G, Murray T, Watkinson G, Brodie M Gut. 1987; 28(3):248-54.
PMID: 3570028 PMC: 1432689. DOI: 10.1136/gut.28.3.248.
Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Holmes B, Ward A Drugs. 1985; 30(4):285-312.
PMID: 2998723 DOI: 10.2165/00003495-198530040-00001.